Investor insights
Sectors invested in
Funding rounds participated in
$103M sweet spot round size
Most of their 12 investments are in rounds between $53M and $160M
Investor type
Basic info
Industry
Sectors
Date founded
2010
Investments made
Cellares raised $255M on August 23, 2023
Investors: Decheng Capital, DFJ Growth, Koch Disruptive Technologies, Bristol-Myers Squibb, UK, 8VC, Eclipse Ventures and Willett Advisors LLC
Carmot Therapeutics, Inc. raised $150M on May 25, 2023
Investors: TCG X, The Column Group, Millennium Partners, RA Capital Management, L.P. and Willett Advisors LLC
Carmot Therapeutics, Inc. raised $160M on July 26, 2022
Investors: Horizons Ventures, The Column Group, RA Capital Management, L.P. and Willett Advisors LLC
Carmot Therapeutics, Inc. raised $160M on July 26, 2022
Investors: Horizons Ventures, RA Capital Management, L.P., The Column Group and Willett Advisors LLC
NextRNA Therapeutics raised $47M on March 1, 2022
Investors: Circle Squared Alternative Investments, Evans Capital, Lightchain Capital LLC, COBRO VENTURES, INC and Willett Advisors LLC
Disc Medicine raised $90M on September 2, 2021
Investors: Atlas Venture, Arix Bioscience plc, OrbiMed Advisors, Novo Holdings and Willett Advisors LLC
Shape Therapeutics Inc. raised $112M on July 15, 2021
Investors: Decheng Capital, Mission BioCapital and Willett Advisors LLC
Circle raised $440M on May 28, 2021
Investors: FTX, Valor Capital Group, Pillar VC, Intersection Fintech Ventures, Digital Currency Group, Marshall Wace and Willett Advisors LLC
Finch Therapeutics Group raised $90M on September 17, 2020
Investors: OMX Ventures, Trans-Pacific Technology Fund, Octave Ventures LLC, Octave Group, Shumway Capital, The Baupost Group, Susquehanna International Group (SIG), OCV and Willett Advisors LLC
Finch Therapeutics Group raised $54M on August 21, 2019
Investors: Trans-Pacific Technology Fund, Susquehanna International Group (SIG), OCV, Shumway Capital, Avenir Growth Capital and Willett Advisors LLC